Safety study of the drug TBN in healthy volunteers
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study tests a new investigational drug called TBN in healthy volunteers to see if it is safe and how the body processes it. It's an early phase trial, so it's not about treating a disease but about understanding the drug's effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 50 years old.
- You need to be generally healthy with no significant long-term illnesses.
- If female, you must not be able to become pregnant (e.g., post-menopausal or surgically sterile).
- If male, you must agree to use contraception and not donate sperm during the study.
- You must avoid tobacco, nicotine, alcohol, and certain medications for a period before dosing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This phase 1 study tests an experimental drug called TIX100 in healthy volunteers to check its safety and how the body processes it. The results will help determine if the drug can be studied in future trials for conditions like obesity or metabolic disorders.
This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.
This early-phase trial tests the safety of a new drug called NTB003 in healthy people. It looks at how the drug moves through the body and affects it, which is a first step toward possibly treating certain conditions.
This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.
This is a first-in-human study to test an investigational drug called PSTB100 in healthy adults. The purpose is to see how the body handles the drug and to check for any side effects. Participation may help with future treatment development.
This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.